DAVID W MANNING

Allopathic & Osteopathic Physicians|Orthopaedic Surgery BURR RIDGE, IL NPI 1962567792

General Payments — all program years on this page

$3,000,734.07

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 222
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $72,924.85 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Royalty or License $47,872.467
Consulting Fee $24,300.004
Food and Beverage $399.295
Travel and Lodging $353.102

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
MEDACTA USA, INC. $72,794.9117
Acerta Pharma LLC $129.941

By program year

Program yearAmountRecords
2018 $707,645.9455
2019 $759,205.3536
2020 $664,903.4528
2021 $550,095.1930
2022 $177,219.1726
2023 $68,740.1229
2024 $72,924.8518

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1104317870 AstraZeneca Pharmaceuticals LP $129.94 03/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143686342 MEDACTA USA, INC. $9,700.00 04/18/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1143686486 MEDACTA USA, INC. $900.00 02/01/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1143686490 MEDACTA USA, INC. $12,800.00 05/02/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1143686492 MEDACTA USA, INC. $900.00 08/22/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1143688068 MEDACTA USA, INC. $142.54 04/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143688658 MEDACTA USA, INC. $70.96 04/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143688868 MEDACTA USA, INC. $45.03 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143688874 MEDACTA USA, INC. $10.82 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143695579 MEDACTA USA, INC. $327.20 01/05/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1143697053 MEDACTA USA, INC. $25.90 02/14/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1143698721 MEDACTA USA, INC. $3,585.68 03/07/2024 Royalty or License Undisputed 01/23/2026 View at CMS
1143698723 MEDACTA USA, INC. $2,919.65 06/05/2024 Royalty or License Undisputed 01/23/2026 View at CMS
1143698725 MEDACTA USA, INC. $48.84 08/08/2024 Royalty or License Undisputed 01/23/2026 View at CMS
1143699305 MEDACTA USA, INC. $10,552.76 08/08/2024 Royalty or License Undisputed 01/23/2026 View at CMS
1143699307 MEDACTA USA, INC. $10,481.77 06/05/2024 Royalty or License Undisputed 01/23/2026 View at CMS
1143699309 MEDACTA USA, INC. $9,817.02 03/07/2024 Royalty or License Undisputed 01/23/2026 View at CMS
1143699311 MEDACTA USA, INC. $10,466.74 11/12/2024 Royalty or License Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.